Transcat, Inc. (NASDAQ:TRNS) Shares Sold by Wasatch Advisors LP

Wasatch Advisors LP reduced its position in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 33.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 439,432 shares of the scientific and technical instruments company's stock after selling 223,382 shares during the quarter. Wasatch Advisors LP owned 4.72% of Transcat worth $46,466,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Jones Financial Companies Lllp boosted its stake in Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after purchasing an additional 309 shares during the period. Morgan Dempsey Capital Management LLC purchased a new stake in shares of Transcat during the fourth quarter valued at $143,000. SG Americas Securities LLC acquired a new position in Transcat in the 4th quarter worth approximately $182,000. KLP Kapitalforvaltning AS acquired a new stake in Transcat during the 4th quarter worth about $190,000. Finally, Captrust Financial Advisors purchased a new position in shares of Transcat during the 3rd quarter valued at approximately $201,000. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat Stock Down 2.0 %

TRNS traded down $1.69 on Monday, hitting $82.90. 21,184 shares of the company were exchanged, compared to its average volume of 73,461. The firm has a 50-day moving average price of $77.05 and a two-hundred day moving average price of $95.46. The company has a current ratio of 2.42, a quick ratio of 1.98 and a debt-to-equity ratio of 0.14. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12. The company has a market cap of $771.72 million, a price-to-earnings ratio of 44.81 and a beta of 0.67.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the previous year, the company posted $0.56 earnings per share. On average, equities analysts predict that Transcat, Inc. will post 2.3 earnings per share for the current year.

Insider Activity at Transcat

In related news, Director Craig D. Cairns bought 1,200 shares of the stock in a transaction dated Friday, January 31st. The stock was acquired at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the acquisition, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. This represents a 169.01 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. StockNews.com lowered shares of Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Oppenheimer lowered shares of Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Northland Securities reissued a "market perform" rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, HC Wainwright lowered their target price on shares of Transcat from $126.00 to $106.00 and set a "buy" rating for the company in a research note on Wednesday, January 29th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, Transcat presently has a consensus rating of "Hold" and a consensus target price of $111.50.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.